Editas Medicine Inc Earnings

The next earnings date for Editas Medicine Inc is November 10, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Editas Medicine Inc Earnings

Report Date	Estimated Earnings Per Share
11/10/2025	$-0.33

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Editas Medicine Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
08/06/2025	---	$0	100.00%
07/30/2025	---	$0	100.00%
05/06/2025	Before Market	$-0.92	-39.39%
02/26/2025	Before Market	$-0.55	-67.38%
11/01/2024	Before Market	$-0.75	0.00%
08/07/2024	Before Market	$-0.82	-17.14%
05/08/2024	Before Market	$-0.76	-15.15%
02/28/2024	Before Market	$-0.23	57.41%
11/03/2023	Before Market	$-0.55	3.51%
08/02/2023	Before Market	$-0.56	26.32%
05/05/2023	Before Market	$-0.71	8.97%
02/22/2023	Before Market	$-0.88	-10.00%
11/02/2022	Before Market	$-0.81	5.81%
08/03/2022	Before Market	$-0.78	4.88%
05/04/2022	Before Market	$-0.74	7.50%
02/24/2022	Before Market	$-0.61	15.28%
11/08/2021	Before Market	$-0.57	30.49%
08/04/2021	Before Market	$-0.81	2.41%
05/05/2021	Before Market	$-0.86	-17.81%
02/25/2021	Before Market	$-1	-35.14%
11/05/2020	After Market	$0.12	118.75%
08/06/2020	After Market	$-0.43	46.91%
05/07/2020	Before Market	$-0.69	12.66%
02/26/2020	After Market	$-0.74	-640.00%
11/12/2019	Before Market	$-0.66	8.33%
08/06/2019	After Market	$-0.69	-9.52%
05/07/2019	After Market	$-0.60	-1.69%
02/28/2019	After Market	$-0.52	-62.50%
11/07/2018	After Market	$-0.32	51.52%
08/06/2018	After Market	$-0.82	-22.39%
05/03/2018	After Market	$-0.67	18.29%
03/06/2018	After Market	$-0.84	-7.69%
11/07/2017	After Market	$-0.64	-6.67%
08/09/2017	After Market	$-0.65	8.45%
05/15/2017	After Market	$-0.85	-39.34%
03/03/2017	After Market	$-1.10	-77.42%
11/07/2016	After Market	$-0.59	7.81%
08/09/2016	After Market	$-0.54	0.00%
05/13/2016	After Market	$-0.80	-185.71%
03/30/2016	Before Market	$-4.05	-678.85%

More About Editas Medicine Inc

Website

https://www.editasmedicine.com

Country

USA

Full Time Employees

246

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.

“Editas Medicine Inc Earnings” Can Refer to the Editas Medicine Inc Earnings Date

Some people say “Editas Medicine Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Editas Medicine Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Editas Medicine Inc Stock on the Earnings Date

If you own Editas Medicine Inc stock (EDIT) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Editas Medicine Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Editas Medicine Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Owning Editas Medicine Inc Options on the Earnings Date

If you own Editas Medicine Inc options on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

In addition, the extrinsic values of Editas Medicine Inc options that overlap earnings dates are often higher than other days of the year. In other words, the premiums you pay to own Editas Medicine Inc options are typically higher during that period. In particular, they are frequently higher immediately before earnings and on the day they’re announced.

This makes sense considering that prices are often more volatile on earnings dates for Editas Medicine Inc. That potential volatility is a key factor that affects the premium cost of owning options.

Once the earnings announcement is done and the anticipated price volatility has gone down, the extrinsic values of Editas Medicine Inc options often go down. This is sometimes referred to as volatility crush.

Learning More Editas Medicine Inc Earnings

You can contact us any time if you would like to ask questions about Editas Medicine Inc earnings or anything else related to the stock market.